semaglutide infection FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease How to Use Ozempic® Pen

NP (with practice agreement)

307,308 Additionally, GLP-1R signaling may affect other macrophage functions, such as phagocytosis, migration, and cell survival

The GLP-1 receptor exists in multiple tissues, including immune cells, and theoretical concerns exist about GLP-1 medications potentially modulating immune responses

This review synthesizes the cellular and physiological mechanisms, contrasts incretin-based therapies with lipid-lowering pharmacotherapy, summarizes the principal randomized trials, evaluates the distinction between plaque regression and plaque stabilization, and outlines unresolved questions and clinical-implementation considerations

Additionally, liraglutide, orforglipron, semaglutide, and tirzepatide were associated with increased vomiting risk, while cagrilinitide and exenatide showed no significant increase